ArticleCancer medicine2024

Identification of PSMD11 as a novel cuproptosis- and immune-related prognostic biomarker promoting lung adenocarcinoma progression.

Qiumin Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.